CYTK · Forms 3, 4, 5
Insider trades at CYTOKINETICS INC
2 insiders sold $1.4M of CYTOKINETICS INC stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for CYTOKINETICS INC (CYTK) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Robert I Blum | President & CEO | Option exercise | 7,500 | $10.60 | $80K | Form 4 | |
| Robert I Blum | President & CEO | Sell (10b5-1 plan) | 7,500 | $62.88 | $472K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Option exercise | 3,500 | $7.80 | $27K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Sell (10b5-1 plan) | 3,500 | $61.38 | $215K | Form 4 | |
| Robert I Blum | President & CEO | Option exercise | 7,500 | $10.60 | $80K | Form 4 | |
| Robert I Blum | President & CEO | Sell (10b5-1 plan) | 7,500 | $65.46 | $491K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Option exercise | 3,500 | $7.80 | $27K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Sell (10b5-1 plan) | 3,500 | $68.29 | $239K | Form 4 | |
| Robert E Landry | Director | Sell (10b5-1 plan) | 1,000 | $72.13 | $72K | Form 4 | |
| Robert I Blum | President & CEO | Sell (10b5-1 plan) | 97,926 | $69.33 | $6.8M | Form 4 | |
| Robert I Blum | President & CEO | Option exercise | 7,500 | $10.60 | $80K | Form 4 | |
| Robert I Blum | President & CEO | Sell (10b5-1 plan) | 7,500 | $73.44 | $551K | Form 4 | |
| Robert I Blum | President & CEO | Gift | 1,350 | Form 4 | |||
| Robert I Blum | President & CEO | Gift | 97,926 | Form 4 | |||
| Robert I Blum | President & CEO | Gift | 97,926 | Form 4 | |||
| Robert E Landry | Director | Sell (10b5-1 plan) | 1,000 | $74.66 | $75K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Option exercise | 3,500 | $7.80 | $27K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Sell (10b5-1 plan) | 3,500 | $75.46 | $264K | Form 4 | |
| B Lynne Parshall | Director | Sell (10b5-1 plan) | 5,000 | $71.48 | $357K | Form 4 | |
| Andrew Callos | EVP, Chief Commercial Officer | Option exercise | 10,000 | $23.26 | $233K | Form 4 | |
| Andrew Callos | EVP, Chief Commercial Officer | Sell (10b5-1 plan) | 10,000 | $70.24 | $702K | Form 4 | |
| Robert I Blum | President & CEO | Option exercise | 7,500 | $10.60 | $80K | Form 4 | |
| Robert I Blum | President & CEO | Sell (10b5-1 plan) | 7,500 | $70.24 | $527K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Option exercise | 3,500 | $7.80 | $27K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Sell (10b5-1 plan) | 3,500 | $75.82 | $265K | Form 4 | |
| Robert I Blum | President & CEO | Option exercise | 7,500 | $10.60 | $80K | Form 4 | |
| Robert I Blum | President & CEO | Sell (10b5-1 plan) | 7,500 | $76.76 | $576K | Form 4 | |
| Andrew Callos | EVP, Chief Commercial Officer | Option exercise | 14,000 | $23.26 | $326K | Form 4 | |
| Andrew Callos | EVP, Chief Commercial Officer | Sell (10b5-1 plan) | 14,000 | $79.88 | $1.1M | Form 4 | |
| Robert I Blum | President & CEO | Option exercise | 7,500 | $10.60 | $80K | Form 4 | |
| Robert I Blum | President & CEO | Sell (10b5-1 plan) | 7,500 | $80.87 | $607K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Option exercise | 3,500 | $7.80 | $27K | Form 4 | |
| Fady Ibraham Malik | EVP Research & Development | Sell (10b5-1 plan) | 3,500 | $80.59 | $282K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.